Lawyer profile for UK 2022
Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
Intellectual Property: Patent Attorneys - UK-wide
"Martin is deeply knowledgeable and very flexible."
This content is provided by Martin MacLean
Martin’s principal practice areas include; drafting and global prosecution, defence and opposition, freedom-to-operate and strategic advice. In this regard, he has extensive experience in the conduct of hearings before the European Patent Office, having conducted over 100 hearings. Martin specialises in technologies such as the re-targeting of bacterial toxins, vaccines, expression systems, microbial detection assays, cytokine-based therapeutics, and agrochemicals, and represents clients ranging from UK Government and blue chip biotech companies through to spin-outs and start-ups.
Martin has a strong background in biochemistry and biotechnology, having obtained a first class degree in microbial technology and a PhD for research conducted into the biochemical aspects of acidophilic bacteria, both at Warwick University. He also has a master's degree in IP from the University of London.
Martin acts as a tutor for the UK and European qualifying examinations. He also serves as a lecturer and clinician for the Chartered Institute of Patent Attorneys. Martin qualified as a Patent Attorney in 1999, joined Mathys & Squire in the same year, and became a partner of the firm in 2004.
Chartered Patent Attorney and European Patent Attorney.
Martin is a co-author of ‘Intellectual Property Issues for Bacteriophages‘, a Springer publication (2020), pp. 1-19 Bacteriophages.